Taysha Gene Therapies, Inc.
2021 Q2 - 2025 Q4 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 369 | 0.0% | 67,085 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 141 | 0.0% | 61,005 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 89 | 0.0% | 63,797 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 109 | 0.0% | 63,011 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 122 | 0.0% | 60,665 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 298 | 0.0% | 133,213 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 183 | 0.0% | 63,726 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 109 | 0.0% | 61,547 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 194 | 0.0% | 61,547 | 9/30/2023 |
| 2022 Q1 | 8/11/2023 | 73 | 0.0% | 11,233 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 151 | 0.0% | 12,964 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 229 | 0.0% | 12,314 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 275 | 0.0% | 12,965 | 6/30/2021 |